November 29, 2024 - 22:58

Baird Investment Strategist Ross Mayfield recently shared his insights on the current challenges facing the US stock market. He emphasized that while there are always headwinds in the market, the key question is whether these challenges outweigh the positive factors at play. Mayfield pointed to several critical elements influencing the market, including the upcoming presidential election, earnings expectations, and the monetary policy of the Federal Reserve.
Since October 2022, the stock market has been under pressure from rising Treasury yields, which have hampered upward momentum. Mayfield cautioned that if inflation expectations rise due to potential stimulus measures and tariff policies, it could create a significant obstacle for the market. He projected that the 10-year yield could climb to between 4.5% and 5%.
Furthermore, Mayfield suggested that the current market sentiment, which he described as "getting pretty hot," could lead to a correction of 5-10% in the first half of the upcoming year. Investors should remain vigilant as these factors unfold.
July 20, 2026 - 02:56
From Banker to Broker: Why Lawry Miller Found His True Calling in Mortgage AdviceLawry Miller, the founder of Teachers and Nurses Mortgage & Finance, has spent years navigating the financial services industry. But unlike many advisers who drift into broking as a second career,...
July 19, 2026 - 05:24
India Probe Into Stolen Donations Tests Trust In Temple FinancesA widening investigation into allegedly stolen donations at India`s grand Ram temple in Ayodhya is raising fresh questions about how religious institutions handle the enormous sums of money and...
July 18, 2026 - 17:45
Analog Devices (ADI) at $375: Are Investors Paying an AI Premium for Industrial Tech?Analog Devices, Inc. (ADI) is trading at $375.18 as of July 16th, with a trailing price-to-earnings ratio of 56.63 and a forward P/E that raises questions about valuation. A bullish thesis on the...
July 18, 2026 - 10:04
‘ChatGPT for Doctors’ Mulls New Financing at $20 Billion ValuationOpenEvidence, the artificial intelligence startup that markets its chatbot as a `ChatGPT for doctors,` is considering a new round of financing that could value the company at roughly $20 billion....